Comparison of antibody response following the second dose of SARS-CoV-2 mRNA vaccine in elderly patients with late-stage chronic kidney disease

[1] Gao YD(2021)Risk factors for severe and critically ill COVID-19 patients: a review Allergy 76 428-455

[2] Ding M(2020)CKD is a key risk factor for COVID-19 mortality Nat Rev Nephrol 16 705-706

[3] Dong X(2021)Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients Am J Kidney Dis 78 571-581

[4] Zhang JJ(2021)COVID-19 vaccines and kidney disease Nat Rev Nephrol 17 291-293

[5] Kursat Azkur A(2021)Review of early immune response to SARS-CoV-2 vaccination among patients with CKD Kidney international reports 6 2292-2304

[6] Azkur D(2022)Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study Clin Exp Nephrol 26 305-307

[7] Gan H(2021)Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Lancet (London, England) 398 1407-1416

[8] Sun YL(2003)Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better Am J Kidney Dis 42 1184-1192

[9] Fu W(2021)Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients N Engl J Med 385 661-662

[10] Li W(2021)Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis Kidney Int 100 702-704

[1] Gao YD(2021)Risk factors for severe and critically ill COVID-19 patients: a review Allergy 76 428-455

[2] Ding M(2020)CKD is a key risk factor for COVID-19 mortality Nat Rev Nephrol 16 705-706

[3] Dong X(2021)Humoral and cellular responses to mRNA-1273 and BNT162b2 SARS-CoV-2 vaccines administered to hemodialysis patients Am J Kidney Dis 78 571-581

[4] Zhang JJ(2021)COVID-19 vaccines and kidney disease Nat Rev Nephrol 17 291-293

[5] Kursat Azkur A(2021)Review of early immune response to SARS-CoV-2 vaccination among patients with CKD Kidney international reports 6 2292-2304

[6] Azkur D(2022)Immune response to SARS-CoV-2 vaccination among renal replacement therapy patients with CKD: a single-center study Clin Exp Nephrol 26 305-307

[7] Gan H(2021)Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study Lancet (London, England) 398 1407-1416

[8] Sun YL(2003)Stage of chronic kidney disease predicts seroconversion after hepatitis B immunization: earlier is better Am J Kidney Dis 42 1184-1192

[9] Fu W(2021)Three doses of an mRNA Covid-19 vaccine in solid-organ transplant recipients N Engl J Med 385 661-662

[10] Li W(2021)Humoral response after 3 doses of the BNT162b2 mRNA COVID-19 vaccine in patients on hemodialysis Kidney Int 100 702-704